FDA drug approval timeline extends 6+ months under interim leadership

Without a confirmed permanent commissioner, the FDA will face delays in drug approvals due to reduced bandwidth for reviews and regulatory decisions. The agency’s existing backlog of drug center director positions will exacerbate these delays.

Implied probability (Yes)

72%